Get Updates

FORCE Blog

This blog will cover topics of interest that affect our community. Unless otherwise stated, the blog articles will be written by Sue Friedman, Executive Director of FORCE.

Get Involved > HBOC Community > FORCE Blog

| More

FORCE Blog

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 1,082 other subscribers

Archives

Metastatic Hereditary Breast Cancer Treatment Research: BROCADE 3 Study

July 28, 2016

By Heather Han, MD and Sue Friedman Metastatic Hereditary Breast Cancer Research There are major gaps in research, resources, and support for people with metastatic breast cancer – cancer that has spread beyond the breast and lymph nodes. A promising area of research is focusing on new treatments for hereditary metastatic breast cancer caused by … + read more

Our Top 3 XRAYS Reviews: Why You Should Read Them

July 25, 2016

FORCE’s XRAYS program, funded by the Centers for Disease Control (CDC), serves as a reliable source of information for young breast cancer survivors and high-risk women, helping them navigate the complex world of breast cancer research-related news and information. We review the latest research and media articles for accuracy and relevancy in order to improve … + read more

Cancer Screening Guideline Loopholes and Confusion Jeopardize Coverage of Services: Part II of Access to Care Series

July 5, 2016

by Lisa Schlager Over 2 million women in the U.S. are at high risk for breast cancer due to family history. Additionally, nearly a million Americans carry an inherited BRCA mutation and a number of other genetic mutations have also been linked to increased risk of breast, ovarian and other cancers. Several organizations develop cancer … + read more

National Task Force Guideline Gaps Hinder Access to Genetic Testing

June 17, 2016

by Lisa Schlager Nearly a million Americans carry an inherited BRCA mutation associated with hereditary breast, ovarian cancer, and related cancers (HBOC) and it is estimated that 2.3 million women in the U.S. are at high risk for breast cancer due to family history. A number of other genetic mutations have also been linked to … + read more

Results from the KNOW MORE Survey: Genetic Counseling and Testing in Women with Different Types of Ovarian Cancer

June 2, 2016

KNOW MORE is a campaign designed by FORCE to help women diagnosed with ovarian, fallopian tube, or primary peritoneal cancers make informed decisions about genetic counseling and testing for inherited gene mutations. We kicked off the effort by launching a brief survey to better understand how women with ovarian and related cancers make decisions about genetic … + read more

Blog: What Do the New Guidelines from the National Comprehensive Cancer Network Mean For You?

May 27, 2016

by Lisa Rezende, PhD People with hereditary cancer face many decisions, such as whether or not to have genetic testing, choosing the best type and frequency of cancer screening, and whether or not to manage cancer risk through surgery. Health care providers look to national guidelines to give their patients advice as they make these … + read more

Updates in Research on Treating Hereditary Cancers

May 19, 2016

Note: This post which was originally published 08/4/15 was just updated on 05/19/16. In December 2014, the FDA approved the first targeted therapy for people with BRCA mutations. Lynparza, a type of medication known as a PARP inhibitor, was approved for women with a BRCA mutation to treat advanced ovarian, fallopian tube, or primary peritoneal cancer that has progressed after … + read more

Experience with Oncology Clinical Trial Participation and Impact on Future Trial Design and Conduct

May 10, 2016

Note: Last year, TESARO, a pharmaceutical company developing a new PARP inhibitor for treatment of ovarian cancer and metastatic breast cancer, asked FORCE to help recruit previous clinical trial participants to join focus groups across the U.S. TESARO wanted to understand the patient experience to build clinical trials that are more responsive to patient needs. We … + read more

5 Stories We Love of Strong Women & Mothers: Happy Mother’s Day

May 7, 2016

Mother’s Day 2016 kicks off National Women’s Health Week, which goes from May 8th through May 14th. This is an excellent time to celebrate all of the women who have made a difference in our lives. Although beautiful, Mother’s Day can be an emotional (and sometimes messy) day. Many of us have mothers, grandmothers and … + read more

Receive Personalized Resources and Support Quickly and Easily Through FORCE’s New Peer Navigation Program

April 25, 2016

by Wendy Demming, FORCE Peer Navigator Volunteer I wanted to be a Peer Navigator because it is important for me to help others who are going through an overwhelming diagnosis. I remember being desperate for credible information, and wanting to talk to others who had been in a similar situation. I was so grateful when … + read more

Factors That Influence Decision-making for Genetic Testing in Women with Ovarian Cancer: Early Results from Our KNOW MORE Survey

April 18, 2016

KNOW MORE is a new campaign designed by FORCE to help women diagnosed with ovarian, fallopian tube, or primary peritoneal cancers make informed decisions about genetic counseling and testing for inherited gene mutations. We kicked off the campaign by launching a brief survey to better understand how women with ovarian and related cancers make decisions around … + read more

3 Things You Did Not Know About the XRAYS Scoring System

April 14, 2016

News stories are often misleading, which is why FORCE launched the CDC-Funded XRAYS (eXamining the Relevance of Articles for Young Survivors) program in the first place– to help young breast cancer survivors and those at high risk for breast cancer better understand health news stories. While many viewers opt in to see the weekly XRAYS … + read more

Today is the 4th Annual Ovarian Cancer Day of Silence- Help Us Make an Impact!

April 7, 2016

We are participating in the Ovarian Cancer Day of Silence today and we hope that you will too. The world we live in is often over-stimulated. To break through the noise, a simple act of silence can go a long way in creating and spreading awareness. Join us in the mission to give women diagnosed with ovarian cancer a … + read more

Update on Pancreatic Cancer Genetics Research

March 30, 2016

By Talia Golan, MD and Sue Friedman, DVM BRCA and pancreatic cancer The link between breast and ovarian cancer and BRCA mutations has been known since the 1990s. However, the awareness that these mutations also increase pancreatic cancer risk is more recent. If all patients with pancreatic cancer were tested for a BRCA1 or BRCA2 … + read more

Ovarian Cancer Survivors with a Negative Genetic Test Result in the Past May Benefit from Additional Genetic Counseling/Testing

March 17, 2016

KNOW MORE is a new campaign designed by FORCE to inform every woman diagnosed with ovarian, fallopian tube, and primary peritoneal cancer about national guidelines on genetic counseling and testing for inherited gene mutations. We kicked off the campaign by launching a brief survey to better understand how women with ovarian cancer make decisions around … + read more

Connect with others.

Call our Helpline

Our helpline offers peer support for people concerned about hereditary cancer. All calls are confidential. Call any time.

Join a Local Group

FORCE has outreach groups throughout the United States and in Essex, United Kingdom that meet periodically to offer peer support, and share resources.

FORCE:Facing Our Risk of Cancer Empowered